3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
15
Gastrointestinal
2
Breast
2
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
74
Lung Neoplasms
35
Adenocarcinoma of Lung
6
Pancoast Syndrome
2
NSCLC
2
Mesothelioma, Malignant
2
Carcinoma
2
Unresectable Non-small Cell Lung Cancer
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
SCLC, Limited Stage
1
Respiratory Aspiration
1
Resectable Non-small Cell Lung Cancer
1
Pulmonary Disease, Chronic Obstructive
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Pleural Diseases
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Mesothelioma
1
Locally Advanced Non-Small Cell Lung Cancer
1
Limited Stage Small Cell Lung Cancer
1
II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Acute Kidney Injury
1
Interventions
pembrolizumab
42
Carboplatin
24
Cyclophosphamide
20
Paclitaxel
19
Nivolumab
17
Cisplatin
15
fludarabine
14
Gemcitabine
12
aldesleukin
10
Docetaxel
10
Bevacizumab
9
Magnetic Resonance Spectroscopy
8
Trastuzumab
7
Specimen Handling
7
Drug Therapy
7
Pemetrexed
6
Oxaliplatin
6
Ipilimumab
6
Interleukin-2
6
Fluorouracil
6
Cetuximab
6
Blood Specimen Collection
6
sargramostim
5
pegfilgrastim
5
avelumab
5
Topotecan
5
Taxes
5
Irinotecan
5
palbociclib
4
durvalumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Surgical Procedures, Operative
×
Thoracic
×
Clear all
NCT06281860
2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1
Unknown
39 enrolled